Uzbekistan's pharmaceutical sector is currently undergoing a rapid modernization phase. However, the region's extreme continental climate—characterized by scorching summers and freezing winters—poses a significant challenge for maintaining stable temperatures in the synthesis of pharmaceutical intermediates, necessitating the use of a high-grade heat transfer fluid.
Many local facilities still rely on traditional oil-based cooling, which often fails under the rigorous chemical environments of advanced organic synthesis. The transition toward PFPE oil is becoming critical as Uzbekistan seeks to align its production standards with global GMP (Good Manufacturing Practice) requirements.
The demand for non-reactive, non-flammable, and chemically stable fluids is surging as Tashkent and other industrial hubs integrate more automated, electronic-heavy synthesis reactors that require specialized electronic testing fluid for quality assurance.
